  PHARMGATE Porcine Reproductive & Respiratory Syndrome Vaccine, Respiratory Form, Modified Live Virus. This product has been shown to be effective for the vaccination of healthy swine, three weeks of age or older, against Porcine Reproductive & Respiratory Syndrome virus. Duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov. The vaccine has been shown to be effective against lung lesions due to Porcine Reproductive & Respiratory Syndrome Virus-associated pneumonia. ADMINISTRATION AND DOSAGE: The desiccated vaccine is rehydrated with the accompanying liquid diluent, mixed well and used immediately. Dose: 1.0 ml intramuscularly (I.M.). |
|
|
|
|
Please contact us for discount pricing on large orders. Call toll free 1-800-892-6978 or email us at info@animalhealthusa.com | |||||||||||
